Company Overview of Regulus Therapeutics Inc.
Paul C. Grint M.D.
Chief Executive Officer, President and Director, Regulus Therapeutics Inc.
|Age||Total Calculated Compensation||This person is connected to 5 Board Members in 5 different organizations across 11 different industries.|
See Board Relationships
As of Fiscal Year 2015
3545 John Hopkins CourtPhone: 858-202-6300
San Diego, California 92121
Board Members Memberships
Non-Executive Director and Member of Compensation Committee
Chief Executive Officer, President and Director
Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Saint Bartholomew Medical School, London University
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Andrew Rackear J.D.||Chief Executive Officer and Secretary|
Enzon Pharmaceuticals Inc.
|Gregory West CA||Chief Executive Officer and Company Secretary|
Benitec Biopharma Limited
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Executive Director|
Arbutus Biopharma Corporation
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|Robert W. Overell Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
|$324.2K||Compensation as of Fiscal Year 2013.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.